Phytohormones: Multifunctional nutraceuticals against metabolic syndrome and comorbid diseases

Biochem Pharmacol. 2020 May:175:113866. doi: 10.1016/j.bcp.2020.113866. Epub 2020 Feb 20.

Abstract

Metabolic syndrome is characterized by the co-occurrence of diverse symptoms initiating the development of type 2 diabetes, cardiovascular diseases, and a variety of comorbid diseases. The complex constellation of numerous comorbidities makes it difficult to develop common therapeutic approaches that ameliorate these pathological features simultaneously. The plant hormones abscisic acid, salicylic acid, auxin, and cytokinins, have shown promising anti-inflammatory and pro-metabolic effects that could mitigate several disorders relevant to metabolic syndrome. Intriguingly, besides plants, human cells and gut microbes also endogenously produce these molecules, indicating a role in the complex interplay between inflammatory responses associated with metabolic syndrome, the gut microbiome, and nutrition. Here, we introduce how bioactive phytohormones can be generated endogenously and through the gut microbiome. These molecules subsequently influence immune responses and metabolism. We also elaborate on how phytohormones can beneficially modulate metabolic syndrome comorbidities, and propose them as nutraceuticals.

Keywords: Food supplement; Gut microbiome; Metabolic syndrome; Phytohormones.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / immunology
  • Diabetes Mellitus, Type 2 / metabolism
  • Dietary Supplements*
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / immunology
  • Humans
  • Inflammation
  • Metabolic Syndrome / drug therapy*
  • Metabolic Syndrome / immunology
  • Metabolic Syndrome / metabolism
  • Plant Growth Regulators / biosynthesis
  • Plant Growth Regulators / pharmacology*

Substances

  • Plant Growth Regulators